ABUS
Arbutus Biopharma
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
ABUS fundamentals
Arbutus Biopharma (ABUS) expects to report earnings on Aug 7, 2025, with estimated revenue of 1.63M (YoY -5.57%), and EPS at -0.066377 (YoY +39.66%).
Revenue estimate / YoY
1.63M
-5.57%
EPS estimate / YoY
-0.066377
+39.66%
Report date
Aug 7, 2025
EPS
Revenue
Revenue & Expenses
ABUS has released its 2025 Q1 earnings report, with revenue of 1.76M, reflecting a YoY change of 15.14%, and net profit of -24.53M, showing a YoY change of -37.21%. The Sankey diagram below clearly presents ABUS's revenue sources and cost distribution.
Key Indicators
Arbutus Biopharma (ABUS) key financial stats and ratios, covering profitability, financial health, and leverage.
Arbutus Biopharma (ABUS)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Arbutus Biopharma (ABUS)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Arbutus Biopharma (ABUS)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Arbutus Biopharma (ABUS) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Arbutus Biopharma (ABUS) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Arbutus Biopharma’s latest dividend and current dividend yield?What is the market’s earnings forecast for Arbutus Biopharma next quarter?What is the revenue and EPS growth rate for Arbutus Biopharma year over year?What does Arbutus Biopharma do and what are its main business segments?Did Arbutus Biopharma beat or miss consensus estimates last quarter?How were Arbutus Biopharma’s latest financial results overall?What is Arbutus Biopharma’s gross profit margin?What factors drove the changes in Arbutus Biopharma’s revenue and profit?